Lista de obras -

4CMenB Immunization Induces Serum Bactericidal Antibodies Against Non-Serogroup B Meningococcal Strains in Adolescents

artículo científico publicado en 2020

A universal vaccine for serogroup B meningococcus

artículo científico publicado en 2006

Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88

artículo científico publicado en 2011

Bactericidal antibodies against hypervirulent <i>Neisseria meningitidis</i> C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in children

artículo científico publicado en 2020

Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies

artículo científico publicado en 2010

Epitope mapping of a bactericidal monoclonal antibody against the factor H binding protein of Neisseria meningitidis.

artículo científico publicado en 2008

Exploiting chimeric human antibodies to characterize a protective epitope of Neisseria adhesin A, one of the Bexsero vaccine components

artículo científico publicado en 2015

Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined

artículo científico publicado en 2016

Four-component Meningococcal Serogroup B Vaccine Induces Antibodies With Bactericidal Activity Against Diverse Outbreak Strains in Adolescents

scientific article published on 13 October 2020

Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1.

scientific article published on 03 December 2010

Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection

scientific article published on 10 January 2010

Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines

artículo científico publicado en 2012

Investigation on the effect of immune selection on resistance to bactericidal antibodies to group B meningococci in vitro

artículo científico publicado en 2009

Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus.

artículo científico publicado en 2010

Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates

scientific article published on 06 October 2020

NadA, a novel vaccine candidate of Neisseria meningitidis

artículo científico publicado en 2002

NarE: a novel ADP-ribosyltransferase from Neisseria meningitidis

artículo científico publicado en 2003

Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans

artículo científico publicado en 2010

Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment

artículo científico publicado en 2013

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

artículo científico publicado en 2010

Rational design of a meningococcal antigen inducing broad protective immunity

artículo científico publicado en 2011

Recognition of Neisseria meningitidis by the long pentraxin PTX3 and its role as an endogenous adjuvant

artículo científico publicado en 2015

RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodies

artículo científico publicado en 2011

The impact of genomics on vaccine design

artículo científico publicado en 2005

The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies

artículo científico publicado en 2005

Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870

artículo científico publicado en 2003

Lista de obras de

4CMenB Immunization Induces Serum Bactericidal Antibodies Against Non-Serogroup B Meningococcal Strains in Adolescents

A universal vaccine for serogroup B meningococcus

Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88

Bactericidal antibodies against hypervirulent <i>Neisseria meningitidis</i> C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in children

Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies

Epitope mapping of a bactericidal monoclonal antibody against the factor H binding protein of Neisseria meningitidis.

Exploiting chimeric human antibodies to characterize a protective epitope of Neisseria adhesin A, one of the Bexsero vaccine components

Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined

Four-component Meningococcal Serogroup B Vaccine Induces Antibodies With Bactericidal Activity Against Diverse Outbreak Strains in Adolescents

Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1.

Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection

Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines

Investigation on the effect of immune selection on resistance to bactericidal antibodies to group B meningococci in vitro

Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus.

Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates

NadA, a novel vaccine candidate of Neisseria meningitidis

NarE: a novel ADP-ribosyltransferase from Neisseria meningitidis

Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans

Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

Rational design of a meningococcal antigen inducing broad protective immunity

Recognition of Neisseria meningitidis by the long pentraxin PTX3 and its role as an endogenous adjuvant

RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodies

The impact of genomics on vaccine design

The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies

Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870